Sotatercept FDA approval follows trial at Norton Pulmonary Specialists
Sotatercept was recently approved by the Food and Drug Administration (FDA) to treat adults with pulmonary arterial hypertension (PAH) after completing a Phase 3 clinical trial at Norton Pulmonary Specialists and other leading pulmonary hypertension [...]
View moreA case study comparing a pulmonology consult with ChatGPT results
Artificial intelligence (AI) like ChatGPT can compose essays or emails, write computer code, even generate art, but how well can it manage complex patient care? A team that included Norton Healthcare researchers decided to find […]
View moreApril 2024 Norton Children’s Medical Group New Providers
Dana L. Gibson, M.D. Pediatrics Richard E. McCarthy, M.D. Pediatric Orthopedic Surgery Clinton M. Nowicke, Psy.D. Developmental-Behavioral Pediatrics Tara B. Clarke, APRN Pediatric Cardiology Jessica R. Coleman, APRN Pediatric Endocrinology Kelsie L. […]
View moreApril 2024 Norton Medical Group New Providers
John T. Garner, M.D. Hospital Medicine Ishan J. Parikh, D.O. Hospital Medicine Aleksandr Pevtsov, D.O. Emergency Medicine Elizabeth Fahey, PA-C Orthopedic Hand Surgery Amy Seldon, PA-C Emergency Medicine Gregory A. Hart, APRN Emergency Medicine Amy […]
View moreNorton Medical Center emergency department in Jeffersonville Commons open for patients of all ages
Norton Healthcare continues its focus of expanding access to health care in Jeffersonville, Indiana. Additional emergency and diagnostic services are now available at Norton Medical Center in the Jeffersonville Commons shopping center, 2023 Mercy Way. […]
View moreOptimizing general health and well-being through ‘prehab’ can improve surgical outcomes
Prehabilitation, or “prehab,” refers to optimizing general health and well-being before surgery to improve surgical outcomes. Prehab takes a multidisciplinary approach, focusing on strength and aerobic exercises, nutrition, smoking cessation, alcohol reduction, and psychological factors […]
View morePhase 1 cystic fibrosis trial studying novel enzyme replacement therapy in adults
Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The [...]
View moreSciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve
The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]
View moreMarch 2024 Norton Children’s Medical Group New Providers
Pamela C Biddle, M.D. Pediatrics Jessica N.B. Easterling, M.D. Pediatrics Kelly E Kries, MD Pediatrics Casey L Miles, MD Pediatrics Danielle R. Lunsford, APRN Developmental-Behavioral Pediatrics Mary C. Oechslin, APRN Pediatrics Chelsea R. Sabelhaus, […]
View moreMarch 2024 Norton Medical Group new providers
Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery […]
View moreUpdated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s
In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]
View moreNorton Healthcare, Norton Children’s launch $200 million fundraising campaign
Not-for-profit Norton Healthcare and Norton Children’s ask for the community’s help to improve health and quality of life for every person in Kentucky and Southern Indiana. The organization, along with local and community leaders, announced […]
View more